Sigyn Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2015 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Sigyn Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2015 to Q3 2024.
  • Sigyn Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 1.27M shares, a 14.7% increase year-over-year.
  • Sigyn Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 1.1M shares, a 17.7% increase from 2022.
  • Sigyn Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 935K shares, a 97.4% decline from 2021.
  • Sigyn Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 36.4M shares, a 395% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 1.27M +163K +14.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-19
Q2 2024 1.24M +155K +14.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-19
Q1 2024 1.23M +269K +27.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 1.1M +165K +17.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 1.11M -36.2M -97% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-19
Q2 2023 1.08M -36.2M -97.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-19
Q1 2023 962K -36.3M -97.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 935K -35.5M -97.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 37.3M +574K +1.56% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 37.3M +885K +2.43% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 37.3M +2.03M +5.75% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 36.4M +29M +395% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 36.7M +36.2M +7244% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 36.4M +35.9M +7182% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 35.3M +34.8M +6953% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 7.35M +6.85M +1370% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-21
Q3 2020 500K -41.8K -7.72% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 500K -80.8M -99.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 500K -80.8M -99.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 500K -64.6M -99.2% Oct 29, 2019 Dec 31, 2019 10-K 2021-04-06
Q3 2019 542K -64.9M -99.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 81.3M +19.4M +31.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 81.3M +23.6M +40.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 65.1M +18M +38.2% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 65.5M +17.4M +36.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 61.9M +17.5M +39.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-05
Q1 2018 57.7M +14M +32% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-19
Q4 2017 47.1M Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 48M +13.6M +39.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 44.3M +9.93M +28.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 43.7M +9.38M +27.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q3 2016 34.4M +2.68M +8.44% Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-14
Q2 2016 34.4M +4.2M +13.9% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-04
Q1 2016 34.3M +4.34M +14.5% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-09
Q4 2015 31M Oct 1, 2015 Dec 31, 2015 10-K 2016-03-30
Q3 2015 31.7M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 30.2M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 30M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.